Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Stroke
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Stroke
    Dabigatran Superior to Warfarin for Reducing Strokes, Major Bleeding Events in Patients With AF: Presented at AHA - (DGDispatch)
    FDA Investigates Risk of Cardiovascular Events in Patients Using Sibutramine - (DGNews)
    Cardiovascular Outcomes Appear Similar for Ezetimibe/Simvastatin and Monotherapy Simvastatin or Atorvastatin: Presented at AHA - (DGDispatch)
    FDA: Avoid Coadministration of Clopidogrel and Omeprazole, Esomeprazole - (DGNews)
    Darbepoetin Alfa Risky for Type 2 Diabetics With Kidney Disease: Presented at AHA - (DGDispatch)

    News archive

     Recent webcasts/CME - Stroke
    • The Evolving Role of Antiplatelet Therapy for Atrial Fibrillation: Highlights From the ACC Scientific Sessions 2009
    • Current Standard of Care for Stroke Prevention in Patients With Atrial Fibrillation (AF)
    • Aneurysm Rupture and Subarachnoid Hemorrhage Cerebral Revascularization: The Role of EC-IC Bypass in the 21st Century
      Stenting for Intracranial Atherosclerosis
      Diffusion-Weighted Imaging: Not All That Glitters Is Gold

      Webcasts/CME archive

       Recent cases - Stroke
        Adult Cor Triatriatum Presenting as Cardioembolic Stroke
        Pure Sensory Stroke Form Compression of Putaminal Hemorrhage: A Case Report
        An Echocardiographic-Confirmed Case of Atrial Myxoma Causing Cerebral Embolic Ischemic Stroke: A Case Report
        Diffusion-Negative MRI in Acute Ischemic Stroke: A Case Report
        F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for the Diagnosis of Takayasu's Arteritis in Stroke: A Case Report

        Cases archive
          




        my personal edition > stroke > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        C-Reactive Protein May Predict MI and Early Death, But Not Stroke

        ST. PAUL, Minn -- October 20, 2009 -- People with high levels of C-reactive protein (CRP) may be at higher risk for myocardial infarction (MI) and death, but not stroke, according to a study published in the October 20 print issue of the journal Neurology.

        The study involved 2,240 people from the Northern Manhattan Study who were aged 40 years or older who had never had a stroke. Of the group, 63% were Hispanic, 20% were non-Hispanic black, and 15% were non-Hispanic white residents.

        All participants had their blood tested for CRP levels and were evaluated for stroke and MI risk factors. They were followed for an average of 8 years. In that time, there were 198 strokes, 156 heart-related events, and 586 deaths.

        The researchers found that people with CRP levels greater than 3 mg per liter were 70% more likely to suffer a MI and 55% more likely to die early compared with people who had levels of 1 milligram per liter or less of the protein in their blood.

        The protein was not associated with an increased risk of stroke once other risk factors were taken into account.

        "The role of this protein in predicting risk of stroke has been controversial although prior studies have found it to be a marker for predicting risk of heart disease," said study author Mitchell Elkind, MD, Columbia University Medical Center, New York, New York.

        "However, in our large, multiethnic population, CRP levels did not play a role in predicting stroke, though they may still help determine whether someone is at risk of heart attack or early death."

        "It appears that by living a healthy lifestyle, one may be able to lower these protein levels, thus lowering the risk of cardiac events and possibly early death," said Dr. Elkind.

        "It may be that the failure of CRP to predict stroke in our study, unlike in some other populations, reflects the fact that our population is older and has more of these risk factors. While CRP may be predictive in generally young healthy people, it may be less useful among older, sicker people."

        "More research needs to be done on why the protein wasn't able to predict stroke in the same manner as heart disease," he concluded.

        SOURCE: American Academy of Neurology



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send